Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
Business

Hedge Fund Managers Are Aggressively Buying Biotech Stocks Despite Trump Hinting at Pharma Tariffs

Pharma companies were spared from Trump's tariff announcement last week.

Since US President Donald Trump announced his sweeping tariff policies on 3rd April, the US stock market indexes have declined sharply, wiping out trillions of dollars of investor money. The deteriorating trade war faces more unpredictability as the tariffs go into effect today, and Trump increased the surcharge on China imports to 104% in response to the mainland's reciprocal tariffs.

The CBOE volatility index (VIX) reached dangerous levels of above 60 this week and remains above 50, signalling extreme fear and panic among investors. Amid the massive sell-off in US equities, hedge fund managers are reshuffling their portfolios to reduce risk exposure stemming from Trump's economic policies.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.